Tanggot, Juven A.

HRN: 28-61-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/20/2026
02/27/2026
IV
50mg
Q24h
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines